Olmesartan Recall 2019: Facts, Background, and Key Details
Finance
The U.S. Food and Drug Administration (FDA) announced multiple voluntary recalls of olmesartan-containing medications due to the detection of N-nitrosodiethylamine (NDEA) and ot...
Open article